California BanCorp CA vs Capital Bancorp
BCAL and CBNK side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BCAL and CBNK compare
California BanCorp CA and Capital Bancorp are about the same size, with market caps of $702M and $681M.
On earnings, California BanCorp CA is cheaper: it trades at 11.9× trailing earnings, against 12.3× for Capital Bancorp.
Capital Bancorp grew revenue faster over the last twelve months (15.1% versus 4.3% for California BanCorp CA).
California BanCorp CA keeps more of each dollar of sales as profit, with a net margin of 33.4% compared with 22.2% at Capital Bancorp.
Both pay dividends: California BanCorp CA yields 1.9% and Capital Bancorp 1.2%.
Capital Bancorp scores higher on the StockData Score (16 against 13 for California BanCorp CA), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BCAL | CBNK |
|---|---|---|
| Size and price | ||
| Market cap | $702M | $681M |
| Share price | $21.85 | $41.78 |
| Change, 1 year | 15.2% | 50.8% |
| Change, 5 years | 41.9% | 57.7% |
| Beta (5Y) | 0.16 | 0.17 |
| Employees | 288 | 459 |
| StockData Score | ||
| Total score | 13 | 16 (better) |
| Valuation score | 2 | 2 |
| Growth score | 2 | 3 (better) |
| Performance score | 3 | 4 (better) |
| Health score | 5 (better) | 4 |
| Dividend score | 1 | 3 (better) |
| Valuation | ||
| P/E | 11.9× (better) | 12.3× |
| P/S | 3.9× | 2.7× (better) |
| P/B | 1.2× (better) | 1.6× |
| P/FCF | 11.9× | – |
| PEG | 0.40 (better) | 2.26 |
| FCF yield | 8.4% | – |
| Fair value | $21.70 | $35.23 |
| Margin of safety | −0.69% (better) | −18.6% |
| Growth | ||
| Revenue growth (TTM) | 4.3% | 15.1% (better) |
| Revenue growth, 5Y average | – | 12.8% |
| Net income growth (TTM) | 92.6% (better) | 30.3% |
| EPS growth (TTM) | 114% (better) | 27.3% |
| EPS growth, 5Y average | – | 12.8% |
| Profitability | ||
| Net margin | 33.4% (better) | 22.2% |
| FCF margin | 32.9% | – |
| Return on equity | 10.6% | 14.1% (better) |
| Financial health | ||
| Altman Z-score | 0.22 | 0.30 (better) |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.9% (better) | 1.2% |
| Payout ratio | – | 14.0% |
| Years of dividend growth | – | 4 |
| Buyback yield | 1.8% (better) | 1.7% |
| Shareholder yield | 3.7% (better) | 3.0% |
| Ownership | ||
| Held by institutions | 71.0% | 45.4% |
| Held by insiders | 8.6% | 25.6% |
| Insider net buying, 12 months | −$46.0M | $0 (better) |
| Short interest, % of float | 3.1% | 4.5% |
Go deeper
- BCAL stock overview
- BCAL income statement
- BCAL valuation and score
- CBNK stock overview
- CBNK income statement
- CBNK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.